---
title: "Latanoprost - Open-angle glaucoma"
sidebar: mydoc_sidebar
permalink: db00654-mesh-d005902-1.html
toc: false 
---


Path ID: `DB00654_MESH_D005902_1`
{% include image.html url="images/db00654-mesh-d005902-1.png" file="db00654-mesh-d005902-1.png" alt="db00654-mesh-d005902-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C072042 | Latanoprost | Drug |
| UniProt:P43088 | Prostaglandin F2-alpha receptor | Protein |
| GO:0008237 | Metallopeptidase activity | BiologicalProcess |
| GO:0031012 | Extracellular matrix | CellularComponent |
| UBERON:0001796 | Aqueous humor of eyeball | GrossAnatomicalStructure |
| HP:0007906 | Ocular hypertension | PhenotypicFeature |
| MESH:D005902 | Open-angle glaucoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Latanoprost | INCREASES ACTIVITY OF | Prostaglandin F2-Alpha Receptor |
| Prostaglandin F2-Alpha Receptor | POSITIVELY REGULATES | Metallopeptidase Activity |
| Metallopeptidase Activity | DECREASES ABUNDANCE OF | Extracellular Matrix |
| Extracellular Matrix | POSITIVELY CORRELATED WITH | Aqueous Humor Of Eyeball |
| Aqueous Humor Of Eyeball | POSITIVELY CORRELATED WITH | Ocular Hypertension |
| Ocular Hypertension | AFFECTS RISK FOR | Open-Angle Glaucoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00654](https://go.drugbank.com/drugs/DB00654)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991965/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991965/)

Reference: 
  - [https://go.drugbank.com/drugs/DB00654](https://go.drugbank.com/drugs/DB00654)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991965/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991965/)
